Mirai Medical ePORE - HSA Registration DE0509429
Access comprehensive regulatory information for Mirai Medical ePORE in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0509429 and owned by Mirai Medical Ltd. The device was registered on June 21, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Intended for non-responsive or limited responsive tumours. - Intended to improve uptake of pharmaceutical Bleomycin administrated intravenously and/or intratumorally. - Intended for patient of aged 18 and above. - Indicated for local treatment of cutaneous and subcutaneous tumours (melanoma, squamous cell carcinoma, and Kaposi sarcoma), treatment of local skin tumour relapse and electroporation of metastatic cutaneous and subcutaneous tumours from underlying primary breast cancer.